Global EditionASIA 中文双语Français
China
Home / China / Latest

Price of COVID-19 treatment Azvudine cut

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2023-01-18 18:48
Share
Share - WeChat

The price of domestically developed COVID-19 treatment Azvudine, has been cut to 11.58 yuan ($1.75) per tablet, so as to be included in China's updated medical reimbursement list from March, the National Healthcare Security Administration said on Wednesday.

The listing price of the oral treatment online ranges from 270 to 330 yuan per bottle in different regions, according to public information.

The updated list will take effect from March 1. Currently, all COVID-19 treatments are temporarily covered by the country's medical insurance program.

Huang Xinyu, an official with the administration, said during an interview with China Central Television that the price cut is large, and has met expectations of medical insurance authorities, reflected the sincerity of the drug developer and will benefit patients.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US